IL6 and COVID-19: IL-6 is a major cytokine involved in the immunopathophysiology of COVID-19, a characteristic biomarker of cytokine storm and a therapeutic target to reduce inflammation and disease symptoms (Campochiaro and Dagna, 2020; Grifoni et al., 2020; Santa Cruz et al., 2021).